Cntrl+ Inc.
PrivateLast Round
Seed
Apr 1, 2026
Total Funding Raised
$1.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cntrl+ Inc. is a medical device company that manufactures a patented, reusable intravaginal bladder support device designed to prevent stress urinary incontinence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Telemedicine
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cntrl+ Inc. Comparables
Compare Cntrl+ Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Uresta | 94% | |
| Ovala, Inc. | 92% | |
| Watkins-Conti Products, Inc. | 90% |
Cntrl+ Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2026 | ||||
| Grant | Sep 1, 2025 | ||||
| Pre Seed | Nov 1, 2024 |
Key People
Founding team and executive leadership
Cntrl+ Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invest Ottawa | Grant |
| KNDL | Pre Seed |
| Ontario Centre of Innovation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Raised $460K in seed funding.
- Aug 25, 2025
Grew 100% QoQ, from 3 to 6 employees.
Cntrl+ Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access